Trial Profile
A Multi-Center, Randomized, Double-Masked Evaluation of the Efficacy of Administration of FOV1101-00 (Cyclosporine Low Dose and High Dose) and Prednisolone Acetate Compared to Its Components and Vehicle in Patients With Mild Ongoing Ocular Allergic Inflammation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Prednisolone/ciclosporin (Primary) ; Prednisolone acetate
- Indications Allergic conjunctivitis
- Focus Therapeutic Use
- Sponsors Fovea Pharmaceuticals
- 07 May 2014 New trial record